
What Did the EVANTHEA Study Reveal About Precision Medicine for Alzheimer’s Disease?
For years, people diagnosed with Mild Cognitive Impairment (MCI) or early Alzheimer’s disease were often told that there was little they could do beyond monitoring symptoms and considering medications designed to slow decline.
The EVANTHEA Study challenged that assumption.







